Butyrate supplementation, a metabolite produced by the microbiota, promotes an increased frequency of IL-10+ Bregs in rheumatoid arthritis patients, and mice lacking IL-10 producing B cells do not experience the same disease suppression following butyrate treatment (154). The gene discussed is IL10; the disease is rheumatoid arthritis.